Computed tomography and cystic fibrosis: promises and problems

Area of Science:

• Radiology and Medical Imaging
• Pulmonology
• Clinical Research Methodology

Background:

• Cystic Fibrosis (CF) lung disease requires sensitive outcome measures for clinical trials.
• Traditional pulmonary function tests are often insensitive to early structural lung damage in CF.
• Rapid advancements in CF therapeutics necessitate novel monitoring tools.

Purpose of the Study:

• To review the research applications of computed tomography (CT) in cystic fibrosis (CF) lung disease.
• To evaluate the evidence supporting CT as a surrogate outcome measure in CF clinical trials.

Main Methods:

• Review of current literature on CT in CF research.
• Emphasis on studies investigating CT as a surrogate outcome measure.
• Analysis of the suitability and controversies surrounding CT in clinical trials.

Main Results:

• CT has established roles in diagnosing CF complications.
• Emerging evidence suggests CT's potential as a surrogate outcome measure in CF research.
• CT may offer greater sensitivity to early structural lung damage compared to traditional methods.

Conclusions:

• CT is a valuable tool for evaluating CF lung disease, particularly in research settings.
• Further investigation is needed to solidify CT's role as a validated surrogate outcome measure for CF clinical trials.
• CT's ability to detect early structural changes makes it a promising tool for monitoring therapeutic efficacy in CF.